Therapeutic Targeting of Autosomal Parkinson's Disease by Modulation of Leucine-Rich Repeat Kinase 2 (LRRK2) Protein. Hyderi Z, Farhana M S, Singh TP, Ravi AV, et al. Brain Res 2025;1860:149674.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hyderi Z, Farhana M S, Singh TP, Ravi AV, et al. Therapeutic Targeting of Autosomal Parkinson's Disease by Modulation of Leucine-Rich Repeat Kinase 2 (LRRK2) Protein. Brain Res 2025;1860:149674.
PMID: 40345365